Head and Neck Cancer News
AI has been used in oncology for years, but recent studies suggest AI could have many additional applications in cancer care.
Good oral health is associated with improved survival in patients with head and neck cancer, a study suggests.
Using next-generation sequencing to guide treatment is feasible in patients with platinum-refractory head and neck cancer, according to researchers.
The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.
A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.
Researchers say they have quantified the global burden of lip and oral cavity cancers as well as other pharyngeal cancers.
Ocular side effects of immune checkpoint inhibitors are considered rare but may be underreported.
Some cancer centers have lifted mask mandates that were intended to protect patients from COVID-19, despite patient concerns.
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
The Preserving Patient Access to Home Infusion Act could make home infusions more accessible, particularly for patients with cancer.
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
Higher cardiorespiratory fitness may protect men from lung, head and neck, gastrointestinal, and genitourinary cancers.
Industry-sponsored cancer trials are more likely to have consent documents translated to languages other than English, a study suggests.
Black and Hispanic patients have a higher risk of death from second primary cancers than White and Asian/Pacific Islander patients, new data suggest.
The FDA has issued a complete response letter related to the new drug application for avasopasem manganese to treat radiotherapy-induced severe oral mucositis in patients with head and neck cancer undergoing standard treatment.
In an analysis of more than 10,000 cancer clinical trials, less than half had results reported within 1 year of trial completion.
New research suggests that, in the United States, cancer was underdiagnosed during the first year of the COVID-19 pandemic.
Excessive alcohol consumption may be common among cancer survivors and cancer patients currently receiving treatment, a new study suggests.